KOREN BLANKLEY: Open Payments
NPI 1275982613 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 13 payments from 8 companies in 2025. Trend: 2023 $267 · 2024 $280 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $47 |
| Lilly USA, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $28 |
| ABBVIE INC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $20 |
| Abbott Laboratories | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Boston Scientific Corporation | 1 | $14 |
Products named: MOUNJARO, SHINGRIX, VOQUEZNA, VRAYLAR, Veozah, ETERNA, TRELEGY ELLIPTA, JOURNAVX.
Industry payments across IN — which companies pay providers there.
